IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 381 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $209,654 | -2.5% | 4,622 | -5.0% | 0.12% | -22.0% |
| Q3 2022 | $215,000 | +5.9% | 4,866 | -11.3% | 0.16% | +23.3% |
| Q1 2022 | $203,000 | -12.1% | 5,489 | -20.3% | 0.13% | -22.3% |
| Q3 2021 | $231,000 | -16.6% | 6,888 | -0.7% | 0.17% | -16.2% |
| Q2 2021 | $277,000 | -12.1% | 6,936 | -1.0% | 0.20% | -18.9% |
| Q1 2021 | $315,000 | -20.7% | 7,005 | -0.2% | 0.24% | -26.9% |
| Q4 2020 | $397,000 | – | 7,021 | – | 0.33% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bellevue Group AG | 9,930,245 | $396,117,000 | 3.87% |
| Sicart Associates LLC | 368,409 | $14,696,000 | 3.50% |
| Camber Capital Management LP | 2,000,000 | $79,780,000 | 2.69% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 181,781 | $7,251,000 | 1.91% |
| SECTOR GAMMA AS | 263,488 | $10,511,000 | 1.86% |
| Parkman Healthcare Partners LLC | 136,380 | $5,440,000 | 1.19% |
| Eversept Partners, LP | 442,000 | $17,631,380 | 1.18% |
| Affinity Asset Advisors, LLC | 75,000 | $2,992,000 | 1.07% |
| TANAKA CAPITAL MANAGEMENT INC | 16,661 | $665,000 | 0.90% |
| Sonora Investment Management, LLC | 168,665 | $6,728,000 | 0.88% |